STK40 inhibits trophoblast fusion by mediating COP1 ubiquitination to degrade P57Kip2

被引:1
作者
Li, Xia [1 ,2 ]
Shao, Li-Zhen [1 ,2 ]
Li, Zhuo-Hang [2 ,3 ]
Wang, Yong-Heng [1 ,2 ]
Cai, Qin-Yu [1 ,2 ]
Wang, Shun [1 ]
Chen, Hong [1 ,2 ]
Sheng, Jie [1 ,2 ]
Luo, Xin [2 ,4 ]
Chen, Xue-Mei [2 ]
Wang, Ying-Xiong [1 ]
Ding, Yu-Bin [2 ]
Liu, Tai-Hang [1 ,2 ]
机构
[1] Chongqing Med Univ, Sch Basic Med Sci, Dept Bioinformat, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Joint Int Res Lab Reprod & Dev, Box 197,1 Yixueyuan Rd, Chongqing 400016, Peoples R China
[3] Tradit Chinese Med Hosp Yaan, Med Lab Dept, Yaan 625099, Sichuan, Peoples R China
[4] Chongqing Med Univ, Affiliated Hosp 1, Dept Obstet, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
P57(Kip2); STK40; Placenta; Trophoblast; Cell fusion; Preeclampsia; EXPRESSION; REVEALS;
D O I
10.1186/s12967-024-05360-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background:<bold> </bold>The syncytiotrophoblast (SCT) layer in the placenta serves as a crucial physical barrier separating maternal-fetal circulation, facilitating essential signal and substance exchange between the mother and fetus. Any abnormalities in its formation or function can result in various maternal syndromes, such as preeclampsia. The transition of proliferative villous cytotrophoblasts (VCT) from the mitotic cell cycle to the G0 phase is a prerequisite for VCT differentiation and their fusion into SCT. The imprinting gene P57(Kip2), specifically expressed in intermediate VCT capable of fusion, plays a pivotal role in driving this key event. Moreover, aberrant expression of P57(Kip2) has been linked to pathological placental conditions and adverse fetal outcomes. Methods:<bold> </bold>Validation of STK40 interaction with P57(Kip2) using rigid molecular simulation docking and co-immunoprecipitation. STK40 expression was modulated by lentivirus in BeWo cells, and the effect of STK40 on trophoblast fusion was assessed by real-time quantitative PCR, western blot, immunofluorescence, and cell viability and proliferation assays. Co-immunoprecipitation, transcriptome sequencing, and western blot were used to determine the potential mechanisms by which STK40 regulates P57(Kip2). Results:<bold> </bold>In this study, STK40 has been identified as a novel interacting protein with P57(Kip2), and its expression is down-regulated during the fusion process of trophoblast cells. Overexpressing STK40 inhibited cell fusion in BeWo cells while stimulating mitotic cell cycle activity. Further experiments indicated that this effect is attributed to its specific binding to the CDK-binding and the Cyclin-binding domains of P57(Kip2), mediating the E3 ubiquitin ligase COP1-mediated ubiquitination and degradation of P57(Kip2). Moreover, abnormally high expression of STK40 might significantly contribute to the occurrence of preeclampsia. Conclusions: This study offers new insights into the role of STK40 in regulating the protein-level homeostasis of P57(Kip2) during placental development.
引用
收藏
页数:14
相关论文
共 29 条
  • [1] Gestational Hypertension and Preeclampsia
    Espinoza, Jimmy
    Vidaeff, Alex
    Pettker, Christian M.
    Simhan, Hyagriv
    [J]. OBSTETRICS AND GYNECOLOGY, 2020, 135 (06) : E237 - E260
  • [2] Pre-eclampsia: pathophysiology and clinical implications
    Burton, Graham J.
    Redman, Christopher W.
    Roberts, James M.
    Moffett, Ashley
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 366
  • [3] Regulating the stability and localization of CDK inhibitor p27Kip1 via CSN6-COP1 axis
    Choi, Hyun Ho
    Guma, Sergei
    Fang, Lekun
    Liem Phan
    Ivan, Cristina
    Baggerly, Keith
    Sood, Anil
    Lee, Mong-Hong
    [J]. CELL CYCLE, 2015, 14 (14) : 2265 - 2273
  • [4] Functional Versatility of the CDK Inhibitor p57Kip2
    Creff, Justine
    Besson, Arnaud
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [5] p57Kip2 knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome
    Duquesnes, Nicolas
    Callot, Caroline
    Jeannot, Pauline
    Daburon, Virginie
    Nakayama, Keiichi I.
    Manenti, Stephane
    Davy, Alice
    Besson, Arnaud
    [J]. JOURNAL OF PATHOLOGY, 2016, 239 (03) : 250 - 261
  • [6] STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1
    Durzynska, Izabela
    Xu, Xiang
    Adelmant, Guillaume
    Ficarro, Scott B.
    Marto, Jarrod A.
    Sliz, Piotrek
    Uljon, Sacha
    Blacklow, Stephen C.
    [J]. STRUCTURE, 2017, 25 (02) : 287 - 294
  • [7] p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases
    Gaillot-Durand, Lucie
    Patrier, Sophie
    Aziza, Jacqueline
    Devisme, Louise
    Riera, Anne-Claude
    Marcorelles, Pascale
    Pelluard, Fanny
    Gasser, Bernard
    Mauduit, Claire
    Hajri, Touria
    Massardier, Jerome
    Bolze, Pierre-Adrien
    Golfier, Francois
    Devouassoux-Shisheboran, Mojgan
    Allias, Fabienne
    [J]. HUMAN PATHOLOGY, 2020, 101 : 18 - 30
  • [8] RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma
    Gu, Chunyan
    Lu, Ting
    Wang, Wang
    Shao, Miaomiao
    Wei, Rongfang
    Guo, Mengjie
    Li, Rui
    Qiao, Li
    Hu, Ye
    Zhan, Fenghuang
    Seckinger, Anja
    Hose, Dirk
    Yang, Ye
    [J]. LEUKEMIA, 2021, 35 (06) : 1803 - 1807
  • [9] Serine/Threonine Kinase 40 (Stk40) Functions as a Novel Regulator of Skeletal Muscle Differentiation
    He, Ke
    Hu, Jing
    Yu, Hongyao
    Wang, Lina
    Tang, Fan
    Gu, Junjie
    Ge, Laixiang
    Wang, Hongye
    Li, Sheng
    Hu, Ping
    Jin, Ying
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (01) : 351 - 360
  • [10] MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis
    Heishima, Kazuki
    Mori, Takashi
    Sakai, Hiroki
    Sugito, Nobuhiko
    Murakami, Mami
    Yamada, Nami
    Akao, Yukihiro
    Maruo, Kohji
    [J]. PLOS ONE, 2015, 10 (09):